Atea Pharmaceuticals Inc. (AVIR) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
225 FRANKLIN STREET BOSTON, MA 02110 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments, including: | 578,100 | 646,709 | 764,375 | 850,117 | |||
| Cash and cash equivalents | 143,823 | 188,460 | 764,375 | 850,117 | |||
| Short-term investments | 434,283 | 458,249 | |||||
| Other undisclosed cash, cash equivalents, and short-term investments | (6) | ||||||
| Receivables | 5,815 | ||||||
| Other undisclosed current assets | 12,355 | 14,213 | 8,028 | 7,545 | |||
| Total current assets: | 590,455 | 660,922 | 772,403 | 863,477 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 1,828 | 2,389 | |||||
| Property, plant and equipment | 1,289 | 1,705 | 23 | 48 | |||
| Restricted cash and investments | 198 | ||||||
| Other noncurrent assets | 1,396 | 1,494 | 466 | 107 | |||
| Total noncurrent assets: | 4,513 | 5,786 | 489 | 155 | |||
| TOTAL ASSETS: | 594,968 | 666,708 | 772,892 | 863,632 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 9,948 | 9,109 | 11,315 | 2,803 | |||
| Taxes payable | ✕ | ✕ | ✕ | 2,572 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 4,209 | 2,743 | ||
| Accounts payable | 4,252 | 2,551 | 4,534 | 60 | |||
| Accrued liabilities | 5,696 | 6,558 | |||||
| Deferred revenue | 301,367 | ||||||
| Other undisclosed current liabilities | 22,428 | 9,369 | 45,568 | 11,625 | |||
| Total current liabilities: | 32,376 | 18,478 | 56,883 | 315,795 | |||
| Noncurrent Liabilities | |||||||
| Liabilities, other than long-term debt | 7,400 | 7,658 | 5,932 | 36 | |||
| Accounts payable and accrued liabilities | 5,758 | 5,255 | |||||
| Other liabilities | 5,932 | 36 | |||||
| Operating lease, liability | 1,642 | 2,403 | |||||
| Total noncurrent liabilities: | 7,400 | 7,658 | 5,932 | 36 | |||
| Total liabilities: | 39,776 | 26,136 | 62,815 | 315,831 | |||
| Equity | |||||||
| Equity, attributable to parent | 555,192 | 640,572 | 710,077 | 547,801 | |||
| Common stock | 83 | 83 | 83 | 82 | |||
| Additional paid in capital | 750,737 | 701,052 | 653,964 | 612,879 | |||
| Accumulated other comprehensive income (loss) | 207 | (684) | |||||
| Retained earnings (accumulated deficit) | (195,835) | (59,879) | 56,030 | (65,160) | |||
| Total equity: | 555,192 | 640,572 | 710,077 | 547,801 | |||
| TOTAL LIABILITIES AND EQUITY: | 594,968 | 666,708 | 772,892 | 863,632 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Revenues | 351,367 | 48,633 | ||||
| Gross profit: | 351,367 | 48,633 | ||||
| Operating expenses | (164,162) | (130,650) | (212,990) | (59,663) | ||
| Operating income (loss): | (164,162) | (130,650) | 138,377 | (11,030) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (164,162) | (130,650) | 138,377 | (11,030) | ||
| Other undisclosed income from continuing operations before income taxes | 29,224 | 11,151 | 213 | |||
| Income (loss) from continuing operations before income taxes: | (134,938) | (119,499) | 138,590 | (11,030) | ||
| Income tax expense (benefit) | (1,018) | 3,590 | (17,400) | |||
| Income (loss) from continuing operations: | (135,956) | (115,909) | 121,190 | (11,030) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 121,190 | (11,030) | |
| Other undisclosed net income | 83 | |||||
| Net income (loss) available to common stockholders, diluted: | (135,956) | (115,909) | 121,190 | (10,947) | ||
Comprehensive Income ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | (135,956) | (115,909) | 121,190 | (10,947) | ||
| Other comprehensive income (loss) | 891 | (684) | ||||
| Other undisclosed comprehensive income | ||||||
| Comprehensive income (loss): | (135,065) | (116,593) | 121,190 | (10,947) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (135,065) | (116,593) | 121,190 | (10,947) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.